Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
Clinical trial NCT04678206 · COMPLETED
Trial details
- NCT number
- NCT04678206
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2021-10-21
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.